Home / Latest Reports / Erectile Dysfunction Treatment Market

Erectile Dysfunction Treatment Market by Typeand Application- Global Industry Analysis & Forecast to 2027

Published On : November 2020 Pages : 154 Category: Pharma & Healthcare Report Code : HC1213768

Request Sample Inquiry Before Buying Request for Customization Check Discount

Erectile Dysfunction Treatment MarketByType (Phosphodiesterase Type 5 Inhibitors, Prostaglandin E1) and Application (Hospitals, Clinic, Others)- Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Erectile Dysfunction Treatment Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Erectile dysfunction is a very common sexual problem affecting 100 million people worldwide. It is often contributed by neurological disorders, cardiovascular diseases, diabetes, hormonal imbalance and obesity.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Erectile Dysfunction Treatment Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Pfizer Inc.
  • Dong-A Pharmaceutical Co. Ltd
  • Vivus, Inc.
  • Meda Pharmaceuticals
  • Bayer AG
  • Johnson & Johnson Services
  • Apricus Biosciences
  • Eli Lilly

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2021 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Erectile Dysfunction Treatment Market, ByType, Estimates and Forecast, 2017-2027 ($Million)

o    Phosphodiesterase Type 5 Inhibitors

o    Prostaglandin E1

·         Erectile Dysfunction Treatment Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)

o    Hospitals

o    Clinic

o    Others

·         Erectile Dysfunction Treatment Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    Pfizer Inc.

o    Dong-A Pharmaceutical Co. Ltd

o    Vivus, Inc.

o    Meda Pharmaceuticals

o    Bayer AG

o    Johnson & Johnson Services

o    Apricus Biosciences

o    Eli Lilly

·         Erectile Dysfunction Treatment Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Erectile Dysfunction Treatment Market, By Country

o    U.S. Erectile Dysfunction Treatment Market

o    Canada Erectile Dysfunction Treatment Market

o    Mexico Erectile Dysfunction Treatment Market

o    Europe

§  Europe Erectile Dysfunction Treatment Market, By Country

·         Germany Erectile Dysfunction Treatment Market

o    UK Erectile Dysfunction Treatment Market

o    France Erectile Dysfunction Treatment Market

o    RussiaErectile Dysfunction Treatment Market

o    Italy Erectile Dysfunction Treatment Market

o    Rest of Europe Erectile Dysfunction Treatment Market

o    Asia-Pacific

§  Asia-Pacific Erectile Dysfunction Treatment Market, By Country

o    ChinaErectile Dysfunction Treatment Market

o    Japan Erectile Dysfunction Treatment Market

o    South KoreaErectile Dysfunction Treatment Market

o    India Erectile Dysfunction Treatment Market

o    Southeast AsiaErectile Dysfunction Treatment Market

o    Rest of Asia-Pacific Erectile Dysfunction Treatment Market

o    South America

§  South AmericaErectile Dysfunction Treatment Market

o    Brazil Erectile Dysfunction Treatment Market

o    ArgentinaErectile Dysfunction Treatment Market

o    ColumbiaErectile Dysfunction Treatment Market

o    Rest of South America Erectile Dysfunction Treatment Market

o    Middle East and Africa

§  Middle East and AfricaErectile Dysfunction Treatment Market

o    Saudi ArabiaErectile Dysfunction Treatment Market

o    UAEErectile Dysfunction Treatment Market

o    EgyptErectile Dysfunction Treatment Market

o    NigeriaErectile Dysfunction Treatment Market

o    South Africa Erectile Dysfunction Treatment Market

o    Rest of MEA Erectile Dysfunction Treatment Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Erectile Dysfunction Treatment Market, By Type

5.1.     Introduction

5.2.     Global Erectile Dysfunction Treatment Revenue and Market Share by Type (2017-2021)

5.2.1.  Global Erectile Dysfunction Treatment Revenue and Revenue Share by Type (2017-2021)

5.3.     Phosphodiesterase Type 5 Inhibitors

5.3.1.  Global Phosphodiesterase Type 5 Inhibitors Revenue and Growth Rate (2017-2021)

5.4.     Prostaglandin E1

5.4.1.  Global Prostaglandin E1 Revenue and Growth Rate (2017-2021)

6.       Erectile Dysfunction Treatment Market, By Application

6.1.     Introduction

6.2.     Global Erectile Dysfunction Treatment Revenue and Market Share by Application (2017-2021)

6.2.1.  Global Erectile Dysfunction Treatment Revenue and Revenue Share by Application (2017-2021)

6.3.     Hospitals

6.3.1.  Global Hospitals Revenue and Growth Rate (2017-2021)

6.4.     Clinic

6.4.1.  Global Clinic Revenue and Growth Rate (2017-2021)

6.5.     Others

6.5.1.  Global Others Revenue and Growth Rate (2017-2021)

7.       Erectile Dysfunction Treatment Market, By Region

7.1.     Introduction

7.2.     Global Erectile Dysfunction Treatment Revenue and Market Share by Regions

7.2.1.  Global Erectile Dysfunction Treatment Revenue by Regions (2017-2021)

7.3.     North America Erectile Dysfunction Treatment by Countries

7.3.1.  North America Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2021)

7.3.2.  North America Erectile Dysfunction Treatment Revenue (Million USD) by Countries (2017-2021)

7.3.3.  United States

7.3.3.1.  United States Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.4.  Canada

7.3.4.1.  Canada Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.5.  Mexico

7.3.5.1.  Mexico Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.     Europe Erectile Dysfunction Treatment by Countries

7.4.1.  Europe Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2021)

7.4.2.  Europe Erectile Dysfunction Treatment Revenue (Million USD) by Countries (2017-2021)

7.4.3.  Germany

7.4.3.1.  Germany Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.4.  France

7.4.4.1.  France Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.5.  UK

7.4.5.1.  UK Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.6.  Russia

7.4.6.1.  Russia Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.7.  Italy

7.4.7.1.  Italy Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.     Asia-Pacific Erectile Dysfunction Treatment by Countries

7.5.1.  Asia-Pacific Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2021)

7.5.2.  Asia-Pacific Erectile Dysfunction Treatment Revenue (Million USD) by Countries (2017-2021)

7.5.3.  China

7.5.3.1.  China Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.4.  Japan

7.5.4.1.  Japan Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.5.  Korea

7.5.5.1.  Korea Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.6.  India

7.5.6.1.  India Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.     South America Erectile Dysfunction Treatment by Countries

7.6.1.  South America Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2021)

7.6.2.  South America Erectile Dysfunction Treatment Revenue (Million USD) by Countries (2017-2021)

7.6.3.  Brazil

7.6.3.1.  Brazil Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.4.  Argentina

7.6.4.1.  Argentina Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.5.  Columbia

7.6.5.1.  Columbia Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.     Middle East and Africa Erectile Dysfunction Treatment by Countries

7.7.1.  Middle East and Africa Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2021)

7.7.2.  Middle East and Africa Erectile Dysfunction Treatment Revenue (Million USD) by Countries (2017-2021)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.5.  Egypt

7.7.5.1.  Egypt Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.7.  South Africa

7.7.7.1.  South Africa Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.8.  Turkey

7.7.8.1.  Turkey Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2021)

8.       Company Profiles

8.1.     Pfizer Inc.

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Dong-A Pharmaceutical Co. Ltd

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Vivus, Inc.

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Meda Pharmaceuticals

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Bayer AG

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Johnson & Johnson Services

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Apricus Biosciences

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Eli Lilly

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

9.       Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.1.     Global Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2022-2027)

9.2.     Erectile Dysfunction Treatment Market Forecast by Regions (2022-2027)

9.2.1.  North America Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.1.1.  United States Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.1.2.  Canada Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.1.3.  Mexico Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.2.  Europe Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.2.1.  Germany Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.2.2.  France Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.2.3.  UK Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.2.4.  Russia Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.2.5.  Italy Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.2.6.  Rest of Europe Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.3.  Asia-Pacific Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.3.1.  China Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.3.2.  Japan Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.3.3.  Korea Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.3.4.  India Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.3.5.  Southeast Asia Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.3.6.  Rest of Asia-Pacific Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.4.  South America Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.4.1.  Brazil Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.4.2.  Argentina Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.4.3.  Columbia Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.4.4.  Rest of South America Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.5.  Middle East and Africa Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.5.1.  Saudi Arabia Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.5.2.  United Arab Emirates Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.5.3.  Egypt Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.5.4.  Nigeria Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.5.5.  South Africa Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.5.6.  Turkey Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.2.5.7.  Rest of Middle East and Africa Erectile Dysfunction Treatment Market Forecast (2022-2027)

9.3.     Erectile Dysfunction Treatment Market Forecast by Type (2022-2027)

9.3.1.  Erectile Dysfunction Treatment Forecast by Type (2022-2027)

9.3.2.  Erectile Dysfunction Treatment Market Share Forecast by Type (2022-2027)

9.4.     Erectile Dysfunction Treatment Market Forecast by Application (2022-2027)

9.4.1.  Erectile Dysfunction Treatment Forecast by Application (2022-2027)

9.4.2.  Erectile Dysfunction Treatment Market Share Forecast by Application (2022-2027)

List of Tables

List of Tables and Figures:

Figure United States Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Erectile Dysfunction Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Erectile Dysfunction Treatment Revenue and Revenue Share by Type (2017-2019)
Figure Global Phosphodiesterase Type 5 Inhibitors Revenue and Growth Rate (2017-2019)
Figure Global Prostaglandin E1 Revenue and Growth Rate (2017-2019)
Table Global Erectile Dysfunction Treatment Revenue and Revenue Share by Application (2017-2019)
Figure Global Hospitals Revenue and Growth Rate (2017-2019)
Figure Global Clinic Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Erectile Dysfunction Treatment Revenue by Regions (2017-2019)
Figure North America Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure North America Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2019)
Figure North America Erectile Dysfunction Treatment by Countries (2017-2019)
Figure North America Erectile Dysfunction Treatment Revenue (Million USD) by Countries (2017-2019)
Figure United States Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure United States Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Canada Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Mexico Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Europe Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2019)
Figure Europe Erectile Dysfunction Treatment by Countries (2017-2019)
Figure Europe Erectile Dysfunction Treatment Revenue (Million USD) by Countries (2017-2019)
Figure Germany Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Germany Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure France Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure UK Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Russia Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Italy Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Rest of Europe Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Asia-Pacific Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Erectile Dysfunction Treatment by Countries (2017-2019)
Figure Asia-Pacific Erectile Dysfunction Treatment Revenue (Million USD) by Countries (2017-2019)
Figure China Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure China Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Japan Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Korea Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure India Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Southeast Asia Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure South America Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2019)
Figure South America Erectile Dysfunction Treatment by Countries (2017-2019)
Figure South America Erectile Dysfunction Treatment Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Brazil Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Argentina Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Columbia Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Rest of South America Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Middle East and Africa Erectile Dysfunction Treatment Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Erectile Dysfunction Treatment by Countries (2017-2019)
Figure Middle East and Africa Erectile Dysfunction Treatment Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Saudi Arabia Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure United Arab Emirates Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Egypt Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Nigeria Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure South Africa Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Turkey Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Erectile Dysfunction Treatment Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Table Pfizer Inc. Erectile Dysfunction Treatment Financial Overview
Table Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Financial Overview
Table Vivus, Inc. Erectile Dysfunction Treatment Financial Overview
Table Meda Pharmaceuticals Erectile Dysfunction Treatment Financial Overview
Table Bayer AG Erectile Dysfunction Treatment Financial Overview
Table Johnson & Johnson Services Erectile Dysfunction Treatment Financial Overview
Table Apricus Biosciences Erectile Dysfunction Treatment Financial Overview
Table Eli Lilly Erectile Dysfunction Treatment Financial Overview
Figure Global Erectile Dysfunction Treatment Revenue (Millions USD) and Growth Rate (2019-2027)
Table Erectile Dysfunction Treatment Market Forecast by Regions (2019-2027)
Figure North America Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure United States Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Canada Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Mexico Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Europe Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Germany Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure France Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure UK Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Russia Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Italy Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Rest of Europe Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Asia-Pacific Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure China Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Japan Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Korea Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure India Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Southeast Asia Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure South America Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Brazil Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Argentina Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Columbia Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Rest of South America Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Middle East and Africa Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Saudi Arabia Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure United Arab Emirates Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Egypt Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Nigeria Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure South Africa Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Turkey Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Erectile Dysfunction Treatment Market Forecast (2019-2027)
Figure Global Erectile Dysfunction Treatment Forecast by Type (2019-2027)
Figure Global Erectile Dysfunction Treatment Market Share Forecast by Type (2019-2027)
Figure Global Erectile Dysfunction Treatment Forecast by Type (2019-2027)
Figure Global Erectile Dysfunction Treatment Forecast by Application (2019-2027)
Figure Global Erectile Dysfunction Treatment Market Share Forecast by Application (2019-2027)
Figure Global Erectile Dysfunction Treatment Forecast by Application (2019-2027)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*